David Libich, PhD to Receive CPRIT Grant to Study, “A Novel Approach to Targeting Ewing Sarcoma.”

June 2, 2026

 REPOST: UT Health SA Newsroom Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Jane Alvarez Hernandez Principal investigator: David Libich, PhD Associate professor in the Department of Biochemistry and Structural Biology in the Long School of Medicine and investigator with the Greehey Children’s Cancer Research Institute Award amount $250,000 Ewing sarcoma is a rare and aggressive cancer [...]


Dr. Raushan Kurmasheva’s laboratory has been awarded a $400K NCI SBIR Phase II grant titled “Enhanced overall survival in high-risk pediatric tumors using a novel oral small molecule.”

January 7, 2026

 Federal Awarding Agency: NIH/NCI Project Title: Enhanced overall survival in high-risk pediatric tumors using a novel oral small molecule. Sub PI: Raushan Kurmasheva, PhD Start: 9/15/25 End: 9/14/27 Amount: $401,844 Project Summary: The research in this NCI-SBIR phase 2 contract focuses on developing a therapeutic for rare pediatric cancers. The original phase 1 contract was [...]